House Bill No. 350 aims to enhance the management and administration of glucagon medication in public and private schools in Texas. The bill introduces new definitions for "glucagon medication" and clarifies the terms "school" and "school employee" to include open-enrollment charter schools. It mandates that school districts and private schools may adopt policies for the maintenance, administration, and disposal of glucagon medication, allowing school nurses or unlicensed diabetes care assistants to administer the medication to students experiencing hypoglycemia, provided that a diabetes management plan and an individualized health plan are in place.

Additionally, the bill allows physicians to prescribe glucagon medication in the name of the school and provides guidelines for the administration of the medication without requiring a patient-specific standing order. It also stipulates that schools are not obligated to purchase glucagon medication if it would impose a financial burden. The provisions of this act will take effect starting with the 2025-2026 school year, and it will become effective immediately if it receives a two-thirds majority vote in both houses of the legislature.

Statutes affected:
Introduced: Health and Safety Code 168.001 (Health and Safety Code 168)